Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Filing Details

Accession Number:
0001127602-12-010611
Form Type:
4
Zero Holdings:
No
Publication Time:
2012-03-13 20:23:39
Reporting Period:
2011-03-14
Filing Date:
2012-03-13
Accepted Time:
2012-03-13 20:23:39
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
850693 Allergan Inc AGN Pharmaceutical Preparations (2834) 951622442
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1016369 D Leonard Schaeffer 2525 Dupont Drive
Irvine CA 92612
No No No Yes
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-03-14 4,250 $71.50 9,050 No 4 P Direct
Common Stock Disposition 2011-05-12 213 $81.09 4,037 No 4 S Direct
Common Stock Disposition 2011-05-13 221 $81.58 3,816 No 4 S Direct
Common Stock Disposition 2011-05-16 91 $81.59 3,725 No 4 S Direct
Common Stock Disposition 2011-09-13 222 $82.01 3,503 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 56,066 Indirect By Family Trust
Footnotes
  1. Purchase of stock in the open market.
  2. Sale of stock in the open market. The reporting person has paid to the issuer all short swing profits under Section 16(b) of the Securities Exchange Act realized on the reported transactions. The transactions were conducted in a discretionary brokerage account without the reporting person's prior knowledge or approval. The sales transactions were conducted subsequent to the reporting person's retirement as a director of the issuer.
  3. The price reported in column 4 is the weighted average price. These shares were sold in multiple transaction at prices ranging from $81.06 to $81.21.
  4. The balance reflects the transfer on May 11, 2011, of 4,800 shares held directly by the reporting person to the Schaeffer Revocable Family Trust dated 10/2/97 established by reporting person as co-settler for the benefit of self and others (the "Family Trust").
  5. Shares held by the Family Trust.